Mouse models of insulin resistance and type 2 diabetes (Q35762322)

10 August 2017

1 reference

title

Mouse models of insulin resistance and type 2 diabetes (English)

1 reference

10 August 2017

1 reference

1 reference

C Postic

1

1 reference

10 August 2017

F Mauvais-Jarvis

series ordinal

2

1 reference

10 August 2017

J Girard

series ordinal

3

1 reference

10 August 2017

publication date

1 February 2004

1 reference

10 August 2017

published in

Annales d'Endocrinologie

1 reference

10 August 2017

volume

65

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

51-59

1 reference

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Extended longevity in mice lacking the insulin receptor in adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Role of brain insulin receptor in control of body weight and reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Pathogenesis of NIDDM. A balanced overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Targeted gene regulation and gene ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Regulatory factor linked to late-onset diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Insulin: new roles for an ancient hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Correction of diabetic alterations by glucokinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Allosteric activators of glucokinase: potential role in diabetes therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Extending the glucose/fatty acid cycle: a glucose/adipose tissue cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Muscle-specific Pparg deletion causes insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Mouse models of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Insulin-promoter-factor 1 is required for pancreas development in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Genetic modifiers of the insulin resistance phenotype in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Insulin receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Conditional control of gene expression in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Myostatin Knockout in Mice Increases Myogenesis and Decreases Adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

P27 knockout mice: reduced myostatin in muscle and altered adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Gene-altered mice and metabolic flux control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Life without white fat: a transgenic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Cell-specific Expression and Regulation of a Glucokinase Gene Locus Transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Effects of Increased Glucokinase Gene Copy Number on Glucose Homeostasis and Hepatic Glucose Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Reduced β-cell mass and altered glucose sensing impair insulin-secretory function in βIRKO mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Cell-specific roles of glucokinase in glucose homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Early-onset type-II diabetes mellitus (MODY4) linked to IPF1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

Maturity-onset diabetes of the young (MODY).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4266%2804%2995630-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-4266(04)95630-2

1 reference

10 August 2017

1 reference